We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

28 hedge funds and large institutions have $11.4M invested in Greenwich LifeSciences in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more funds holding

Funds holding: 22 → 28 (+6)

12% more capital invested

Capital invested by funds: $10.2M → $11.4M (+$1.21M)

1.22% more ownership

Funds ownership: 5.22% → 6.44% (+1.2%)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
28
Holders Change
+6
Holders Change %
+27.27%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
8
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$589K
2
Millennium Management
Millennium Management
New York
+$541K
3
HF
HRT Financial
New York
+$295K
4
Jane Street
Jane Street
New York
+$294K
5
Renaissance Technologies
Renaissance Technologies
New York
+$278K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$57.9K
2
Morgan Stanley
Morgan Stanley
New York
-$25.4K
3
6CM
683 Capital Management
New York
-$15.1K
4
UBS Group
UBS Group
Switzerland
-$11.5K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$9.38K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.86M +$124K +7,800 +2%
Millennium Management
2
Millennium Management
New York
$963K +$541K +34,081 +95%
Ameriprise
3
Ameriprise
Minnesota
$905K -$666 -42 -0.1%
BlackRock
4
BlackRock
New York
$783K +$92.5K +5,830 +11%
Renaissance Technologies
5
Renaissance Technologies
New York
$701K +$278K +17,500 +53%
Marshall Wace
6
Marshall Wace
United Kingdom
$593K +$8.38K +528 +1%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$551K – – –
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$512K +$589K +37,100 New
HF
9
HRT Financial
New York
$256K +$295K +18,606 New
Jane Street
10
Jane Street
New York
$255K +$294K +18,510 New
State Street
11
State Street
Massachusetts
$179K – – –
GCP
12
GSA Capital Partners
United Kingdom
$175K -$1.9K -120 -0.9%
Citigroup
13
Citigroup
New York
$172K +$198K +12,498 New
6CM
14
683 Capital Management
New York
$148K -$15.1K -953 -8%
Citadel Advisors
15
Citadel Advisors
Florida
$143K +$164K +10,354 New
Morgan Stanley
16
Morgan Stanley
New York
$98.2K -$25.4K -1,600 -18%
Bank of America
17
Bank of America
North Carolina
$79.5K -$57.9K -3,647 -39%
TRCT
18
Tower Research Capital (TRC)
New York
$15K +$16.6K +1,049 +2,017%
NFSG
19
Newbridge Financial Services Group
Florida
$12.4K +$6.35K +400 +80%
FCMT
20
Founders Capital Management (Texas)
Texas
$7K -$7.93K -500 -50%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$2K -$9.38K -591 -84%
Fidelity Investments
22
Fidelity Investments
Massachusetts
$1.58K +$16 +1 +0.9%
NSIM
23
North Star Investment Management
Illinois
$703 – – –
Osaic Holdings
24
Osaic Holdings
Arizona
$690 – – –
AF
25
Advisornet Financial
Minnesota
$690 +$793 +50 New
1
2

GLSI Hedge Fund Activity: Q1 2023 in Review

28 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q1 2023, worth a combined $11.4M — up 12% from $10.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GLSI positions and 0 closed out — a net gain of 6 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $589K. The largest seller was Bank of America, cutting an estimated $57.9K.

  • 28 institutional investors held Greenwich LifeSciences (GLSI) as of Q1 2023, up from 22 in Q4 2022.
  • Funds reported $11.4M of Greenwich LifeSciences stock for Q1 2023, up 12% quarter-over-quarter.
  • 6 funds opened new Greenwich LifeSciences positions in Q1 2023 and 0 closed out, a net change of +6 holders.
  • The largest Greenwich LifeSciences buyer in Q1 2023 was Susquehanna International Group, an estimated $589K added.
  • The largest Greenwich LifeSciences seller in Q1 2023 was Bank of America, an estimated $57.9K sold.

Based on aggregated 13F filings for Q1 2023.